174 related articles for article (PubMed ID: 35862373)
1. VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types.
Sarkar J; Luo Y; Zhou Q; Ivakhnitskaia E; Lara D; Katz E; Sun MG; Guaiquil V; Rosenblatt M
PLoS One; 2022; 17(7):e0269818. PubMed ID: 35862373
[TBL] [Abstract][Full Text] [Related]
2. Heterodimerisation between VEGFR-1 and VEGFR-2 and not the homodimers of VEGFR-1 inhibit VEGFR-2 activity.
Cai M; Wang K; Murdoch CE; Gu Y; Ahmed A
Vascul Pharmacol; 2017 Jan; 88():11-20. PubMed ID: 27884759
[TBL] [Abstract][Full Text] [Related]
3. Trafficking dynamics of VEGFR1, VEGFR2, and NRP1 in human endothelial cells.
Sarabipour S; Kinghorn K; Quigley KM; Kovacs-Kasa A; Annex BH; Bautch VL; Mac Gabhann F
PLoS Comput Biol; 2024 Feb; 20(2):e1011798. PubMed ID: 38324585
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes.
Tanaka K; Watanabe M; Tanigaki S; Iwashita M; Kobayashi Y
Placenta; 2018 Dec; 74():20-27. PubMed ID: 30591201
[TBL] [Abstract][Full Text] [Related]
5. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
6. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
Mac Gabhann F; Popel AS
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333
[TBL] [Abstract][Full Text] [Related]
7. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.
Awasthi N; Schwarz MA; Verma V; Cappiello C; Schwarz RE
Lab Invest; 2009 Jan; 89(1):38-46. PubMed ID: 19002109
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos.
Hiratsuka S; Kataoka Y; Nakao K; Nakamura K; Morikawa S; Tanaka S; Katsuki M; Maru Y; Shibuya M
Mol Cell Biol; 2005 Jan; 25(1):355-63. PubMed ID: 15601856
[TBL] [Abstract][Full Text] [Related]
9. VEGFR1 and VEGFR2 in Alzheimer's Disease.
Harris R; Miners JS; Allen S; Love S
J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
[TBL] [Abstract][Full Text] [Related]
10. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.
Hiratsuka S; Nakao K; Nakamura K; Katsuki M; Maru Y; Shibuya M
Mol Cell Biol; 2005 Jan; 25(1):346-54. PubMed ID: 15601855
[TBL] [Abstract][Full Text] [Related]
11. Multiplexing Angiogenic Receptor Quantification via Quantum Dots.
Chen S; Imoukhuede PI
Anal Chem; 2019 Jun; 91(12):7603-7612. PubMed ID: 31088078
[TBL] [Abstract][Full Text] [Related]
12. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
13. A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.
Clegg LE; Mac Gabhann F
PLoS Comput Biol; 2017 Mar; 13(3):e1005445. PubMed ID: 28319199
[TBL] [Abstract][Full Text] [Related]
14. Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
Szabo E; Schneider H; Seystahl K; Rushing EJ; Herting F; Weidner KM; Weller M
Neuro Oncol; 2016 Sep; 18(9):1242-52. PubMed ID: 27009237
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
16. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent resonance energy transfer imaging of VEGFR dimerization.
Ahmadova Z; Yagublu V; Förg T; Hajiyeva Y; Jesenofsky R; Hafner M; Keese M
Anticancer Res; 2014 May; 34(5):2123-33. PubMed ID: 24778014
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
19. VEGF and his R1 and R2 receptors expression in mast cells of oral squamous cells carcinomas and their involvement in tumoral angiogenesis.
Ciurea R; Mărgăritescu C; Simionescu C; Stepan A; Ciurea M
Rom J Morphol Embryol; 2011; 52(4):1227-32. PubMed ID: 22203927
[TBL] [Abstract][Full Text] [Related]
20. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
